BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3223334)

  • 1. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
    Bloom D; Krishnan B; Thavundayil JX; Lal S
    Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
    Webber SK; Domniz Y; Sutton GL; Rogers CM; Lawless MA
    Cornea; 2001 Mar; 20(2):217-9. PubMed ID: 11248834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
    Ewing DG; Einarson TR
    Am J Psychiatry; 1981 Dec; 138(12):1631-2. PubMed ID: 7304801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
    Lal S; Lal S
    J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia.
    Molina-Ruiz AM; Pulpillo Á; Molina-Ruiz RM; Sagrario T; Requena L
    Int J Dermatol; 2016 Aug; 55(8):909-12. PubMed ID: 26340849
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
    Schreiber G; Belmaker RH
    Biol Psychiatry; 1987 Nov; 22(11):1417-21. PubMed ID: 3663793
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of chlorpromazine pigments in man.
    Van Woert MH
    Nature; 1968 Sep; 219(5158):1054-6. PubMed ID: 5673364
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of Phenothiazine-produced skin pigmentation: a preliminary report.
    Gibbard BA; Lehmann HE
    Am J Psychiatry; 1966 Sep; 123(3):351-2. PubMed ID: 5917622
    [No Abstract]   [Full Text] [Related]  

  • 14. Haloperidol versus chlorpromazine for schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic schizophrenia with tri-iodothyronine.
    Simpson GM; Amuso D
    Can Psychiatr Assoc J; 1966 Aug; 11(4):303-5. PubMed ID: 5967398
    [No Abstract]   [Full Text] [Related]  

  • 17. Schizophrenia and the pineal gland.
    Greiner AC
    Can Psychiatr Assoc J; 1970 Oct; 15(5):433-47. PubMed ID: 5492186
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 19. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
    Serafetinides EA; Willis D; Clark ML
    J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
    Thaler JS; Curinga R; Kiracofe G
    Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.